Literatur
-
1
A report of the
American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (committee on pacemaker implantation) .
ACC/AHA
guidelines for implantation of cardiac pacemakers and antiarrhythmia
devices.
J Am Coll Cardiol.
1998;
31
1175-1209
-
2
Cairns J A, Connolly S J, Roberts R, Gent M.
Randomised trial of outcome
after myocardial infarction in patients with frequent or repetitive
ventricular premature depolarisations: CAMIAT. Canadian Amiodarone
Myocardial Infarction Arrhythmia Trial Investigators.
Lancet.
1997;
349
675-682
-
3
Cappato R.
Secondary
prevention of sudden death: The Dutch Study, the Antiarrhythmics
Versus Implantable Defibrillator Trial, the Cardiac Arrest Study
Hamburg, and the Canadian Implantable Defibrillator Study.
Am
J Cardiol.
1999;
83
68D-73D
-
4
Corrado D, Fontaine G, Marcus F I, McKenna W J, Nava A, Thiene G. for the Study Group on Arrhythmogenic
Right Ventricular Dysplasia /Cardiomyopathy of the Working
Groups on Myocardial and Pericardial Disease and Arrhythmias of
the European Society of Cardiology and of the Scientific Council
on Cardiomyopathies of the World Heart Federation .
Circulation.
2000;
101
E101-106
-
5
Doval H C, Nul D R, Grancelli H O. et al. for the GESICA-GEMA investigators .
Nonsustained
ventricular tachycardia in severe heart failure. Independent marker
of increased mortality due to sudden cardiac death.
Circulation.
1996;
94
3198-3203
-
6
Julian D G, Camm A J, Frangin G. et al .
Randomised trial of effect of amiodarone
on mortality in patients with left ventricular dysfunction after
recent myocardial infarction: EMIAT. European myocardial infarct
amiodarone trial investigators.
Lancet.
1997;
349
667-674
-
7
Kennedy H L, Whitlock J A, Sprague M K, Kennedy L J, Buckingham T A, Goldberg R J.
Long-term
follow-up of asymptomatic healthy subjects with frequent and complex
ventricular ectopy.
N Engl J Med.
1985;
312
193-197
-
8
Kowey P R, Taylor J E, Marinchak R A, Rials S J.
Does programmed ventricular
stimulation really help in the evaluation of patients with nonsustained
ventricular tachycardia? Results of a meta-analysis.
Am
Heart J.
1992;
123
481-485
-
9
Kuck K H.
Arrhythmias
in hypertrophic cardiomyopathy.
Pacing Clin Electrophysiol.
1997;
20
2706-2713
-
10
Levy S.
Arrhythmias
in mitral valve prolapse syndrome: clinical significance and management.
Pacing
Clin Electrophysiol.
1992;
15
1080-1088
-
11
Moss A J, Hall J, Cannom D S, Daubert J P, Higgins S L, Klein H, Levine J H, Saksena S, Waldo A L, Wilber D, Brown M W, Heo M. for the multicenter
automatic defibrillator implantation trial investigators .
Improved
survival with an implanted defibrillator in patients with coronary
artery disease at high risk for ventricular tachycardia.
N
Engl J Med.
1996;
335
1933-1940
-
12
Roden D M.
Mechanism
and management of proarrhythmia.
Am J Cardiol.
1998;
82
49I-57I
-
13
Singh S N, Fletcher R D, Fisher S G. et al .
Amiodarone in patients with congestive
heart failure and asymptomatic ventricular arrhythmia. Survival
Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
N
Engl J Med.
1995;
333
77-82
-
14
Sorgato A, Faggiano P, Aurigemma G P, Rusconi C, Gaasch W H.
Ventricular
arrhythmias in adult aortic stenosis: prevalence, mechanisms, and
clinical relevance.
Chest.
1998;
113
482-491
-
15
Yamani M H, Massie B M.
Hypertension,
myocardial ischemia, and sudden death.
Curr Opin Cardiol.
1994;
9
542-550
Korrespondenz
Prof. Dr. Wolfgang Schöls
Abteilung Innere Medizin III, Medizinische
Universitätsklinik
Bergheimerstraße 58
69115 Heidelberg
Telefon: 06221/568676
Fax: 06221/565515